FFCD 1709-SIRTCI phase II trial: Selective internal radiation therapy plus Xelox, Bevacizumab and Atezolizumab in liver-dominant metastatic colorectal cancer.
暂无分享，去创建一个
C. Cheze-le Rest | P. Laurent-Puig | H. Sokol | C. Lepage | J. Emile | J. Taieb | J. Tasu | B. Guiu | V. Tacher | K. Le Malicot | A. Gagnaire | D. Tougeron | S. Pernot | T. Aparicio | I. Baumgaertner | E. Mitry | J. Edeline | Denis Smith | C. Tabouret-Viaud | T. Bejan-Angoulvant | V. Catena | V. Hautefeuille | C. Capron | V. Randrian | J. Forestier | Anthony Dhomps | R. Perdrisot